birb 796 has been researched along with skepinone-l in 1 studies
| Studies (birb 796) | Trials (birb 796) | Recent Studies (post-2010) (birb 796) | Studies (skepinone-l) | Trials (skepinone-l) | Recent Studies (post-2010) (skepinone-l) |
|---|---|---|---|---|---|
| 137 | 5 | 80 | 17 | 0 | 16 |
| Protein | Taxonomy | birb 796 (IC50) | skepinone-l (IC50) |
|---|---|---|---|
| Heat shock protein beta-1 | Homo sapiens (human) | 0.025 | |
| Cholesteryl ester transfer protein | Homo sapiens (human) | 0.005 | |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | 0.0351 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.0091 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, SM; Boeckler, FM; Fischer, S; Grütter, C; Koeberle, SC; Laufer, SA; Mayer-Wrangowski, SC; Niess, R; Rauh, D; Storch, K; Wentsch, HK; Zimmermann, M | 1 |
1 other study(ies) available for birb 796 and skepinone-l
| Article | Year |
|---|---|
Dibenzosuberones as p38 mitogen-activated protein kinase inhibitors with low ATP competitiveness and outstanding whole blood activity.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Dibenzocycloheptenes; Hydrophobic and Hydrophilic Interactions; Lipopolysaccharides; Models, Molecular; p38 Mitogen-Activated Protein Kinases; Protein Binding; Solubility; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2013 |